09 November 2026
: Case report
[In Press] Resolution of Cardiopulmonary Lesions After Intervention for Rapidly Progressive POEMS-Related Pulmonary Hypertension: A Case Report
Challenging differential diagnosis, Unusual setting of medical care, Rare disease
Shuangshuang Song1ABCDEF, Chengcong Zhu1BC, Juan Wang1BE, Qian Zhang1ADDOI: 10.12659/AJCR.954626
Am J Case Rep In Press; DOI: 10.12659/AJCR.954626
Available online: 2026-11-09, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Pulmonary hypertension is a severe complication of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, and Skin changes (POEMS) syndrome. It can cause severe right heart failure and even death. Vascular endothelial growth factor modulates angiogenesis and vascular hyperpermeability, which is the key mechanism behind this complication. POEMS-related pulmonary hypertension is often misdiagnosed due to its nonspecific manifestations. The optimal regimen remains undefined.
CASE REPORT
A 30-year-old man presented with a 4-month history of dyspnea and bilateral lower extremity weakness. The patient had manifestations of volume overload and received diuretic therapy. Despite this treatment, transthoracic echocardiography showed a rapid rise in estimated pulmonary artery systolic pressure from 55 mm Hg to 109 mm Hg over a 2-month interval. Meanwhile, it also demonstrated thickening of the interventricular septum and left ventricular posterior wall, together with obvious dilation of multiple cardiac chambers. Pulmonary function tests showed severe mixed ventilatory impairment and decreased diffusing capacity of the lung for carbon monoxide. Further evaluations demonstrated more extensive multisystem involvement. Immunofixation electrophoresis and vascular endothelial growth factor testing were performed, confirming the diagnosis of POEMS syndrome. The patient initially received a lenalidomide and dexamethasone regimen and subsequently underwent autologous hematopoietic stem cell transplantation, resulting in significant symptom improvement. At the 10-month follow-up, he remained in sustained symptomatic remission, and relevant monitoring indicators remained within normal ranges.
CONCLUSIONS
Rapidly progressive pulmonary hypertension is a severe yet potentially reversible complication in POEMS syndrome. Lenalidomide and dexamethasone followed by autologous stem cell transplantation can markedly slow disease progression. Our present case illustrates rapid progression and favorable post-treatment improvement in POEMS-associated rapidly progressive pulmonary hypertension.
Keywords: POEMS Syndrome; Pulmonary Arterial Hypertension; Heart Failure
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954600
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954889
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.954405
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.953611
Most Viewed Current Articles
07 Dec 2021 : Case report
28,714,025
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
181,538
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
125,043
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
08 May 2026 : Case report
97,330
DOI :10.12659/AJCR.952158
Am J Case Rep 2026; 27:e952158






